In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Sudden cardiac arrest kills one in five people but cannot be reliably predicted yet

Cardiac Arrest
Acute Cardiac Care

Copenhagen, Denmark – 3 April 2022:  An analysis of more than 10,000 individuals has failed to produce a model that accurately predicts sudden cardiac arrest. The results from the ESCAPE-NET project are presented at EHRA 2022, a scientific congress of the European Society of Cardiology (ESC).1

Dr. Hanno Tan, ESCAPE-NET project leader and cardiologist, Amsterdam University Medical Centre AMC, the Netherlands said: “Our study found that a risk model which includes clinical characteristics such as use of medications to lower blood lipids and blood pressure allowed us to identify people who would not suffer a sudden cardiac arrest over the next 10 years. However, this analysis did not allow us to identify individuals who did suffer a cardiac arrest, meaning that these indicators are not specific enough for population-based prevention programmes.”

Most sudden cardiac arrests occur in the community and in individuals not previously known to have increased risk. A cardiac arrhythmia, called ventricular fibrillation, causes the heart to cease pumping and blood flow stops. If blood flow is not restored in time, the individual passes out and dies within 10 to 20 minutes.

The ESCAPE-NET research project aims to develop a risk prediction model to identify people in the general population at increased likelihood of sudden cardiac arrest. Dr. Tan explained: “If you can predict who is going to suffer from this event and when, then you can take preventative measures such as an implantable cardioverter defibrillator (ICD).”

The study included 10,100 participants from the Copenhagen City Heart Study, of which 56% were women. The average age was 59 years. During a follow-up of 10 years, there were 425 sudden cardiac arrests. Validation of the results was performed in 2,464 participants of the Hoorn Studies.

The investigators found that a previously established model for predicting the 10-year risk of sudden cardiac death in US communities2 could also predict the 10-year risk of sudden cardiac arrest in the Copenhagen and Hoorn cohorts. Variables in the model included baseline age, sex, total cholesterol, lipid-lowering medication use, hypertension medication use, blood pressure, smoking status, diabetes and body mass index.

The researchers found that, although the model identified participants who had a sudden cardiac arrest 10 years later with great sensitivity (92%), it had only modest specificity (63%).

Dr. Tan said: “In view of the low specificity, this model serves primarily to screen, at an early stage, individuals who may have raised risk and require more detailed cardiac examination, rather than providing a direct means to utilise preventive measures such as ICD implants.”

Dr. Tan concluded: “The findings indicate that people in the community may be too heterogeneous to make accurate risk prediction with clinical characteristics alone an attainable goal. This is because while sudden cardiac arrest victims share a final common pathway (ventricular fibrillation), there are many roads leading to it with multiple underlying causes of the arrhythmia. Our consortium is currently examining whether other factors such as genetic variants are associated with elevated risk of sudden cardiac arrest in the general population. This information could then be added to the clinical model and tested for sensitivity and specificity.”

ESCAPE-NET is backed by the European Heart Rhythm Association (EHRA) of the ESC and the European Resuscitation Council (ERC).

 

ENDS

Notes to editor

ESC Press Office
Tel: +33 (0) 7 8531 2036
Email: press@escardio.org

Follow us on Twitter @ESCardioNews

 

Funding: ESCAPE-NET has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733381.

 

Disclosures: None.

 

References and notes

1Session: “The EHRA EU research projects” on 3 April at 15:45 CEST in Room 5.

2Bogle BM, Ning H, Goldberger JJ, et al. A simple community-based risk-prediction score for sudden cardiac death. Am J Med. 2018;131:532–539.

 

About the European Heart Rhythm Association

The European Heart Rhythm Association (EHRA) is a branch of the European Society of Cardiology (ESC). Its aim is to improve patients’ quality of life and reduce sudden cardiac death by limiting the impact of heart rhythm disturbances. 

About the EHRA Congress  #EHRA2022

EHRA 2022 is the annual congress of the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC).

About the European Society of Cardiology

The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.

Information for journalists about registration for EHRA 2022

EHRA 2022 takes 3 to 5 April at the Bella Center in Copenhagen, Denmark and online. Explore the scientific programme.

  • Free registration applies to accredited press.
  • Credentials: A valid press cardor appropriate letter of assignment with proof of three recent published articles. Read the ESC media and embargo policy.
  • The ESC Press Office will verify the documents and confirm by email that your press accreditation is valid.
  • The ESC Press Office decision is final regarding all press registration requests.